🇺🇸 FDA

Company profile · Sponsor

Laboratoire

Laboratoire HRA Pharma

E8493B4 · EMA pharma EU
Pipeline
9
Drugs
0
Patents
0

Quick answer

Laboratoire (E8493B4) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E8493B4
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (9)

Search pipeline →

  1. ACTISOUFRE, solution pour pulvérisation nasale/buccale en flacon pressurisé, Actisoufre Placebo

    Laboratoire

    rhinosinusitis not requiring antibiotic therapy, rhinopharyngitis not requiring antibiotic therapy, Acute rhinitis not requiring antibiotic therapy

    phase 3 small molecule active

    1 trial

  2. Placebo

    Laboratoire

    Leber congenital amaurosis (LCA)

    phase 3 small molecule active

    1 trial

  3. Pravafenix 40 mg/160 mg hard capsules

    Laboratoire

    Dyslipidaemia

    phase 3 small molecule active

    1 trial

  4. Placebo of NAL, NACYSTELYN

    Laboratoire

    Obstructive Sleep Apnea

    phase 2 small molecule active

    1 trial

  5. Preservative-free, ophthalmic solution

    Laboratoire

    Paediatric myopia

    phase 2 small molecule active

    1 trial

  6. Verkazia 1 mg/mL eye drops, emulsion

    Laboratoire

    Vernal Keratoconjunctivitis (VKC)

    phase 2 small molecule active

    1 trial

  7. sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe.

    Laboratoire

    Retinitis Pigmentosa

    phase 2 small molecule active

    1 trial

  8. sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe.

    Laboratoire

    Retinitis Pigmentosa

    phase 2 small molecule active

    1 trial

  9. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire

    Periodontitis

    approved small molecule active

    1 trial

Frequently asked questions

What is Laboratoire?

Laboratoire (E8493B4) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Laboratoire sponsor?

We track 9 ClinicalTrials.gov-linked programs for Laboratoire, including ACTISOUFRE, solution pour pulvérisation nasale/buccale en flacon pressurisé, Actisoufre Placebo and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Laboratoire company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.